A comparison of the effects of commercially available hawthorn preparations on calcium transients of isolated cardiomyocytes

Journal of Medicinal Food

Volumn 11, Issue 4, 2008, Pages 680-686

  Rodriguez, Michelle E ^a   Poindexter, Brian J ^a   Bick, Roger J ^a   Dasgupta, Amitava ^a  

^a UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

Author keywords

Cardiac; Fluorescence; Hawthorn; Imaging; Myocyte

Indexed keywords

ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM); CALCIUM; CRATAEGUS EXTRACT; NIFEDIPINE; OUABAIN;

ANIMAL CELL; ARTICLE; BERRY; CALCIUM CELL LEVEL; CALCIUM TRANSPORT; CARDIOVASCULAR EFFECT; CELL ISOLATION; CONCENTRATION RESPONSE; CRATAEGUS; DRUG EFFECT; DRUG MECHANISM; DRUG POTENCY; DRUG POTENTIATION; DRUG PROTEIN BINDING; FLOWER; HEART BEAT; HEART MUSCLE CELL; MALE; NEWBORN; NONHUMAN; PLANT LEAF; PRIORITY JOURNAL; RAT; SPECTROFLUOROMETRY;

ANIMALS; CALCIUM; CALCIUM CHANNEL BLOCKERS; CARDIOTONIC AGENTS; CRATAEGUS; HEART FAILURE; HERB-DRUG INTERACTIONS; HYPERTENSION; MALE; MYOCYTES, CARDIAC; NIFEDIPINE; PHYTOTHERAPY; PLANT COMPONENTS; PLANT EXTRACTS; RATS; RATS, SPRAGUE-DAWLEY; SODIUM-POTASSIUM-EXCHANGING ATPASE;

CRATAEGUS; RATTUS; STROPHANTHUS GRATUS;

EID: 57349117287     PISSN: 1096620X     EISSN: None     Source Type: Journal    
DOI: 10.1089/jmf.2008.0080     Document Type: Article

References (19)

1. Islam J, Uretsky BF, Sierpina S: Heart failure improvement with CoQ10, hawthorn and magnesium in a patient scheduled for cardiac resynchronization- defibrillation therapy. EXPLORE 2006;2:339-341.
2. Kocyildiz ZC, Birman H, Olgac V, Akgun-Dar K, Melikoglu G, Mericli AH: Crataegus tanacetifolia leaf extract prevents L-NAME-induced hypertension in rats: a morphological study. Phytother Res 2006;20:66-70.
3. Walker AF, Marakis G, Simpson E, Hope JL, Robinson PA, Hassanein M, Simpson HC: Hypotensive effects of hawthorn for patients with diabetes taking prescription drugs: a randomized controlled trial. Br J Gen Pract 2006;56:437-443.
4. Pittler MH, Schmidt K, Ernst E: Hawthorn extract for treating chronic heart failure: meta-analysis of randomized trials. Am J Med 2003;114:665-674.
5. Popping S, Rose H, Ionescu I, Fischer Y, Kammermeier H: Effect of hawthorn extract on contraction and energy turnover of isolated rat cardiomyocytes. Arzneimittelforschung 1995;45:1157-1161.
6. Long SR, Carey RA, Crofoot KM, Proteau PJ, Filtz TM: Effect of hawthorn (Crataegus oxycantha) crude extract and chromatographic fractions on multiple activities in a cultured cardiomyocyte assay. Phytomedicine 2006;13:643-650.
7. Li SC, Huang H, Zheng FM, Wen DL, Mo SW: [Effects of yixintong on regulating cellular calcium channels]. Zhongguo Zhong Yao Za Zhi 2003;28:754-756.
8. Daniele C, Mazzanti G, Pittler MH, Ernst E: Adverse-event profile of Crataegus spp.: a systematic review. Drug Saf 2006;29:523-535.
9. Chang Q, Zuo Z, Ho WK, Chow MS: Comparison of the pharmacokinetics of hawthorn phenolics in extract versus individual pure compound. J Clin Pharmacol 2005;45:106-112.
10. Bick RJ, Poindexter BJ, Sweney R, Dasgupta A: Effects of Chan Su, a traditional Chinese medicine, on the calcium transients of isolated cardiomyocytes: cardiotoxicity due to more than Na,K-ATPase blocking. Life Sci 2002;72:699-709.
11. Poindexter BJ, Allison AW, Bick RJ, Dasgupta A: Ginseng: cardiotonic in adult cardiomyocytes, cardiotoxic in neonatal cardiomyocytes. Life Sci 2006;7:2337-2344.
12. Poindexter BJ, Feng W, Dasgupta A, Bick RJ: Oleandrin produces changes in intracellular calcium levels in isolated cardiomyocytes; a real-time fluorescence imaging study comparing adult to neonatal cardiomyocytes. J Toxicol Environ Health 2006;70:568-574.
13. Chatterjee SS, Koch E, Jaggy H, Krzeminski T: In vitro and in vivo studies on the cardioprotective action of oligomeric procyanidins in a Crataegus extract of leaves and blooms. Arzeneimittelforschung 1997;47:821-825.
14. Zapfe jun G: Clinical efficacy of Crataegus extract WS 1442 in congestive heart failure NYHA class II. Phytomedicine 2001;8:262-266.
15. Holubarsch CJ, Colucci WS, Meinertz T, Gaus W, Tendera M: Crataegus extract WS 1442 postpones cardiac death in patients with congestive heart failure class NYHA II-III: a randomized, placebo-controlled, double-blind trial in 2681 patients. Presented at the American College of Cardiology Scientific Sessions, New Orleans, LA, March 27, 2007. http://www.medscape.com/viewarticle/554233 (accessed March 2008).
16. Hanus M, Lafon J, Mathieu M: Double-blind, randomised, placebo-controlled study to evaluate the efficacy and safety of a fixed combination containing two plant extracts (Crataegus oxyacantha and Eschscholtzia californica) and magnesium in mild-to-moderate anxiety disorders. Curr Med Res Opin 2004;20:63-71.
17. McGovern PE, Zhang J, Tang J, Zhang Z, Hall GR, Moreau RA, Nunez A, Butrym ED, Richards MP, Wang CS, Cheng G, Zhao Z, Wang C: Fermented beverages of pre- and proto-historic China. Proc Natl Acad Sci U S A 2004;101:17593-17598.
18. Fonnebo F, Grimsgaard S, Walach H, Ritenbaugh C, Norheim AJ, MacPherson H, Lewith G, Launzo L, Koithan M, Falkenberg T, Boon H, Aickin M: Researching complementary and alternative treatments - the gatekeepers are not at home. BMC Med Res Methodol 2007;7:7-12.
19. Bakalar N: Regimens: an herbal extract eases symptoms of heart failure. The New York Times February 5, 2008. http://nytimes.com.2008 (accessed March 2008)